Navarro S - Search Results

1

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

Kohler JA, Rubie H, Castel V, Beiske K, Holmes K, Gambini C, Casale F, Munzer C, Erminio G, Parodi S, Navarro S, Marquez C, Peuchmaur M, Cullinane C, Brock P, Valteau-Couanet D, Garaventa A, Haupt R. Kohler JA, et al. Among authors: navarro s. Eur J Cancer. 2013 Nov;49(17):3671-9. doi: 10.1016/j.ejca.2013.07.002. Epub 2013 Jul 29. Eur J Cancer. 2013. PMID: 23907002 Clinical Trial.

2

The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies.

Castel V, García-Miguel P, Melero C, Navajas A, Navarro S, Molina J, Badal MD, Ruiz-Jimenez JI. Castel V, et al. Among authors: navarro s. Eur J Cancer. 1995;31A(4):642-5. doi: 10.1016/0959-8049(95)00072-q. Eur J Cancer. 1995. PMID: 7576986 Clinical Trial.

3

Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma.

Mejia MC, Navarro S, Pellin A, Castel V, Llombart-Bosch A. Mejia MC, et al. Among authors: navarro s. Anticancer Res. 1998 Mar-Apr;18(2A):801-6. Anticancer Res. 1998. PMID: 9615722

4

Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma.

Mejía C, Navarro S, Colamonici OR, Pellín A, Castel V, Llombart-Bosch A. Mejía C, et al. Among authors: navarro s. Oncol Rep. 1999 Jan-Feb;6(1):149-53. Oncol Rep. 1999. PMID: 9864419

5

Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.

Castel V, García-Miguel P, Cañete A, Melero C, Navajas A, Ruíz-Jiménez JI, Navarro S, Badal MD. Castel V, et al. Among authors: navarro s. Eur J Cancer. 1999 Apr;35(4):606-11. doi: 10.1016/s0959-8049(98)00395-5. Eur J Cancer. 1999. PMID: 10492635

6

Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients.

Cañete A, Navarro S, Bermúdez J, Pellín A, Castel V, Llombart-Bosch A. Cañete A, et al. Among authors: navarro s. J Clin Oncol. 2000 Jan;18(1):27-34. doi: 10.1200/JCO.2000.18.1.27. J Clin Oncol. 2000. PMID: 10623690

7

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

Castel V, Cañete A, Navarro S, García-Miguel P, Melero C, Acha T, Navajas A, Badal MD. Castel V, et al. Among authors: navarro s. Med Pediatr Oncol. 2001 Dec;37(6):537-42. doi: 10.1002/mpo.1248. Med Pediatr Oncol. 2001. PMID: 11745893 Clinical Trial.

8

Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors.

del Carmen Mejía M, Navarro S, Pellín A, Ruíz A, Castel V, Llombart-Bosch A. del Carmen Mejía M, et al. Among authors: navarro s. Arch Med Res. 2002 Sep-Oct;33(5):466-72. doi: 10.1016/s0188-4409(02)00384-3. Arch Med Res. 2002. PMID: 12459317

9

Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.

Mejía C, Navarro S, Pellín A, Ruíz A, Castel V, Llombart-Bosch A. Mejía C, et al. Among authors: navarro s. Oncol Rep. 2003 Jan-Feb;10(1):243-7. Oncol Rep. 2003. PMID: 12469176

10

MYCN gain and MYCN amplification in a stage 4S neuroblastoma.

Noguera R, Cañete A, Pellín A, Ruiz A, Tasso M, Navarro S, Castel V, Llombart-Bosch A. Noguera R, et al. Among authors: navarro s. Cancer Genet Cytogenet. 2003 Jan 15;140(2):157-61. doi: 10.1016/s0165-4608(02)00677-5. Cancer Genet Cytogenet. 2003. PMID: 12645655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters